Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Henlin, JM; Boutin, JA; Duchene-Roger, F; Nicolas, JP; Desmet-Beaufort, C; Levens, N; Fauchere, JL
   Parallel synthesis and pharmacological screening oi nonpeptide ligands of the neuropeptide Y receptor subtype Y-5
   JOURNAL OF PEPTIDE RESEARCH
   
   J.M. Henlin et al., "Parallel synthesis and pharmacological screening oi nonpeptide ligands of the neuropeptide Y receptor subtype Y-5", J PEPT RES, 57(5), 2001, pp. 419-427
2. Ali, MA; Bhogal, N; Fishwick, CWG; Findlay, JBC
   Spatial requirements of the antagonist binding site of the NK2 receptor
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   M.A. Ali et al., "Spatial requirements of the antagonist binding site of the NK2 receptor", BIOORG MED, 11(6), 2001, pp. 819-822
3. Petit, T; Davidson, KK; Lawrence, RA; von Hoff, DD; Izbicka, E
   Neuropeptide receptor status in human tumor cell lines
   ANTI-CANCER DRUGS
   
   T. Petit et al., "Neuropeptide receptor status in human tumor cell lines", ANTI-CANC D, 12(2), 2001, pp. 133-136
4. Souaze, F
   Maintaining cell sensitivity to G-protein coupled receptor agonists: Neurotensin and the role of receptor gene activation
   JOURNAL OF NEUROENDOCRINOLOGY
   
   F. Souaze, "Maintaining cell sensitivity to G-protein coupled receptor agonists: Neurotensin and the role of receptor gene activation", J NEUROENDO, 13(5), 2001, pp. 473-479
5. Gurrath, M
   Peptide-binding G protein-coupled receptors: New opportunities for drug design
   CURRENT MEDICINAL CHEMISTRY
   
   M. Gurrath, "Peptide-binding G protein-coupled receptors: New opportunities for drug design", CURR MED CH, 8(13), 2001, pp. 1605-1648
6. Thibonnier, M; Coles, P; Thibonnier, A; Shoham, M
   The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists
   ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
   
   M. Thibonnier et al., "The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists", ANN R PHARM, 41, 2001, pp. 175-202
7. Peterlin-Masic, L; Kikelj, D
   Arginine mimetics
   TETRAHEDRON
   
   L. Peterlin-Masic e D. Kikelj, "Arginine mimetics", TETRAHEDRON, 57(33), 2001, pp. 7073-7105
8. Blaney, FE; Raveglia, LF; Artico, M; Cavagnera, S; Dartois, C; Farina, C; Grugni, M; Gagliardi, S; Luttmann, MA; Martinelli, M; Nadler, GMMG; Parini, C; Petrillo, P; Sarau, HM; Scheideler, MA; Hay, DWP; Giardina, GAM
   Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists
   JOURNAL OF MEDICINAL CHEMISTRY
   
   F.E. Blaney et al., "Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists", J MED CHEM, 44(11), 2001, pp. 1675-1689
9. Labrou, NE; Bhogal, N; Hurrell, CR; Findlay, JBC
   Interaction of Met(297) in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   N.E. Labrou et al., "Interaction of Met(297) in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A", J BIOL CHEM, 276(41), 2001, pp. 37944-37949
10. Sarau, HM; Feild, JA; Ames, RS; Foley, JJ; Nuthulaganti, P; Schmidt, DB; Buckley, PT; Elshourbagy, NA; Brawner, ME; Luttmann, MA; Giardina, GAM; Hay, DWP
    Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    H.M. Sarau et al., "Molecular and pharmacological characterization of the murine tachykinin NK3 receptor", EUR J PHARM, 413(2-3), 2001, pp. 143-150
11. Camara, AKS; Osborn, J
    Central AT(1) and AT(2) receptors mediate chronic intracerebroventricular angiotensin II-induced drinking in rats fed high sodium chloride diet from weaning
    ACTA PHYSIOLOGICA SCANDINAVICA
    
    A.K.S. Camara e J. Osborn, "Central AT(1) and AT(2) receptors mediate chronic intracerebroventricular angiotensin II-induced drinking in rats fed high sodium chloride diet from weaning", ACT PHYSL S, 171(2), 2001, pp. 195-201
12. Peyman, A; Gourvest, JF; Gadek, TR; Knolle, J
    Vitronectin receptor antagonists: Purine-based peptidomimetics
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    A. Peyman et al., "Vitronectin receptor antagonists: Purine-based peptidomimetics", ANGEW CHEM, 39(16), 2000, pp. 2874-2877
13. Leroy, V; Mauser, P; Gao, ZL; Peet, NP
    Neurokinin receptor antagonists
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    V. Leroy et al., "Neurokinin receptor antagonists", EXPERT OP I, 9(4), 2000, pp. 735-746
14. Giardina, GA; Grugni, M; Raveglia, LF
    Recent advances in neurokinin-3 receptor antagonists
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    G.A. Giardina et al., "Recent advances in neurokinin-3 receptor antagonists", EXPERT OP T, 10(6), 2000, pp. 939-960
15. Robertson, MJ
    Angiotensin antagonists (Reprinted from Receptor-Based Drug Design, pg 207-230, 1998)
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    
    M.J. Robertson, "Angiotensin antagonists (Reprinted from Receptor-Based Drug Design, pg 207-230, 1998)", J RECEPT SI, 20(4), 2000, pp. 211-234
16. Peyman, A; Wehner, V; Knolle, J; Stilz, HU; Breipohl, G; Scheunemann, KH; Carniato, D; Ruxer, JM; Gourvest, JF; Gadek, TR; Bodary, S
    RGD mimetics containing a central hydantoin scaffold: alpha(v)beta(3) vs alpha(IIb)beta(3) selectivity requirements
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    A. Peyman et al., "RGD mimetics containing a central hydantoin scaffold: alpha(v)beta(3) vs alpha(IIb)beta(3) selectivity requirements", BIOORG MED, 10(2), 2000, pp. 179-182
17. Vannucchi, MG; Faussone-Pellegrini, MS
    NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse
    ANATOMY AND EMBRYOLOGY
    
    M.G. Vannucchi e M.S. Faussone-Pellegrini, "NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse", ANAT EMBRYO, 202(3), 2000, pp. 247-255
18. Massi, M; Panocka, I; de Caro, G
    The psychopharmacology of tachykinin NK-3 receptors in laboratory animals
    PEPTIDES
    
    M. Massi et al., "The psychopharmacology of tachykinin NK-3 receptors in laboratory animals", PEPTIDES, 21(11), 2000, pp. 1597-1609
19. Gether, U
    Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
    ENDOCRINE REVIEWS
    
    U. Gether, "Uncovering molecular mechanisms involved in activation of G protein-coupled receptors", ENDOCR REV, 21(1), 2000, pp. 90-113
20. Patchett, AA; Nargund, RP
    Privileged structures - An update
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    
    A.A. Patchett e R.P. Nargund, "Privileged structures - An update", ANNU REP M, 35, 2000, pp. 289-298
21. Liu, J; Underwood, DJ; Cascieri, MA; Rohrer, SP; Cantin, LD; Chicchi, G; Smith, AB; Hirschmann, R
    Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry
    JOURNAL OF MEDICINAL CHEMISTRY
    
    J. Liu et al., "Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry", J MED CHEM, 43(21), 2000, pp. 3827-3831
22. Mazzone, SB; Geraghty, DP
    Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists
    BRITISH JOURNAL OF PHARMACOLOGY
    
    S.B. Mazzone e D.P. Geraghty, "Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists", BR J PHARM, 129(6), 2000, pp. 1121-1131
23. Miller, MD; Fluder, EM; Castonguay, LA; Culberson, JC; Mosley, RT; Prendergast, K; Kearsley, SK; Sheridan, RP
    MEGA-SQ: A method using the SQuEAL function to find the optimal superposition of several quasi-flexible molecules
    MEDICINAL CHEMISTRY RESEARCH
    
    M.D. Miller et al., "MEGA-SQ: A method using the SQuEAL function to find the optimal superposition of several quasi-flexible molecules", MED CHEM RE, 9(7-8), 1999, pp. 513-534
24. Mayinger, B; Hensen, J
    Nonpeptide vasopressin antagonists: A new group of hormone blockers entering the scene
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    B. Mayinger e J. Hensen, "Nonpeptide vasopressin antagonists: A new group of hormone blockers entering the scene", EXP CL E D, 107(3), 1999, pp. 157-165
25. Pruneau, D; Chorny, I; Benkovitz, V; Artru, A; Roitblat, L; Shapira, Y
    Effect of LF 16-0687MS, a new nonpeptide bradykinin B-2 receptor antagonist, in a rat model of closed head trauma
    JOURNAL OF NEUROTRAUMA
    
    D. Pruneau et al., "Effect of LF 16-0687MS, a new nonpeptide bradykinin B-2 receptor antagonist, in a rat model of closed head trauma", J NEUROTRAU, 16(11), 1999, pp. 1057-1065
26. Schmidt, PT; Rickelt, LF; Holst, JJ
    Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors
    DIGESTIVE DISEASES AND SCIENCES
    
    P.T. Schmidt et al., "Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors", DIG DIS SCI, 44(7), 1999, pp. 1273-1281
27. Mann, JFE
    Valsartan and the kidney: Present and future
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    J.F.E. Mann, "Valsartan and the kidney: Present and future", J CARDIO PH, 33, 1999, pp. S37-S40
28. Rosenkilde, MM; Kledal, TN; Brauner-Osborne, H; Schwartz, TW
    Agonists and inverse agonists for the herpesvirus 8-encoded constitutivelyactive seven-transmembrane oncogene product, ORF-74
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M.M. Rosenkilde et al., "Agonists and inverse agonists for the herpesvirus 8-encoded constitutivelyactive seven-transmembrane oncogene product, ORF-74", J BIOL CHEM, 274(2), 1999, pp. 956-961
29. CHRISTOS TE; ARVANITIS A
    CORTICOTROPIN-RELEASING FACTOR-RECEPTOR ANTAGONISTS
    Expert opinion on therapeutic patents
    
    T.E. Christos e A. Arvanitis, "CORTICOTROPIN-RELEASING FACTOR-RECEPTOR ANTAGONISTS", Expert opinion on therapeutic patents, 8(2), 1998, pp. 143-152
30. SOLDNER A; SPAHNLANGGUTH H; MUTSCHLER E
    HPLC ASSAYS TO SIMULTANEOUSLY DETERMINE THE ANGIOTENSIN-AT(1) ANTAGONIST LOSARTAN AS WELL AS ITS MAIN AND ACTIVE METABOLITE EXP3174 IN BIOLOGICAL-MATERIAL OF HUMANS AND RATS
    Journal of pharmaceutical and biomedical analysis
    
    A. Soldner et al., "HPLC ASSAYS TO SIMULTANEOUSLY DETERMINE THE ANGIOTENSIN-AT(1) ANTAGONIST LOSARTAN AS WELL AS ITS MAIN AND ACTIVE METABOLITE EXP3174 IN BIOLOGICAL-MATERIAL OF HUMANS AND RATS", Journal of pharmaceutical and biomedical analysis, 16(5), 1998, pp. 863-873
31. HAN NL; SIM MK
    HYPOTHALAMIC ANGIOTENSIN RECEPTOR SUBTYPES IN NORMOTENSIVE AND HYPERTENSIVE RATS
    American journal of physiology. Heart and circulatory physiology
    
    N.L. Han e M.K. Sim, "HYPOTHALAMIC ANGIOTENSIN RECEPTOR SUBTYPES IN NORMOTENSIVE AND HYPERTENSIVE RATS", American journal of physiology. Heart and circulatory physiology, 44(2), 1998, pp. 703-709
32. HOLST B; ZOFFMANN S; ELLING CE; HJORTH SA; SCHWARTZ TW
    STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR
    Molecular pharmacology
    
    B. Holst et al., "STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR", Molecular pharmacology, 53(1), 1998, pp. 166-175
33. DASCAL D; NIRULA V; LAWUS K; YOO SE; WALSH TF; SANDBERG K
    SHARED DETERMINANTS OF RECEPTOR-BINDING FOR SUBTYPE-SELECTIVE, AND DUAL ENDOTHELIN-ANGIOTENSIN ANTAGONISTS ON THE AT(1) ANGIOTENSIN-II RECEPTOR
    FEBS letters
    
    D. Dascal et al., "SHARED DETERMINANTS OF RECEPTOR-BINDING FOR SUBTYPE-SELECTIVE, AND DUAL ENDOTHELIN-ANGIOTENSIN ANTAGONISTS ON THE AT(1) ANGIOTENSIN-II RECEPTOR", FEBS letters, 423(1), 1998, pp. 15-18
34. WIELAND HA; ECKARD CP; DOODS HN; BECKSICKINGER AG
    PROBING OF THE NEUROPEPTIDE Y-Y-1-RECEPTORS INTERACTION WITH ANTIRECEPTOR ANTIBODIES
    European journal of biochemistry
    
    H.A. Wieland et al., "PROBING OF THE NEUROPEPTIDE Y-Y-1-RECEPTORS INTERACTION WITH ANTIRECEPTOR ANTIBODIES", European journal of biochemistry, 255(3), 1998, pp. 595-603
35. LASIKOVA A; VEGH D; SMAHOVSKY V
    NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS - POTENTIAL-DRUGS AGAINST HYPERTENSION
    Chemicke listy
    
    A. Lasikova et al., "NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS - POTENTIAL-DRUGS AGAINST HYPERTENSION", Chemicke listy, 92(2), 1998, pp. 133-146
36. JACOBY E; BOUDON A; KUCHARCZYK N; MICHEL A; FAUCHERE JL
    A STRUCTURAL RATIONALE FOR THE DESIGN OF WATER-SOLUBLE PEPTIDE-DERIVED NEUROKININ-1 ANTAGONISTS
    Journal of receptor and signal transduction research
    
    E. Jacoby et al., "A STRUCTURAL RATIONALE FOR THE DESIGN OF WATER-SOLUBLE PEPTIDE-DERIVED NEUROKININ-1 ANTAGONISTS", Journal of receptor and signal transduction research, 17(6), 1997, pp. 855-873
37. NOZAWA Y; HARUNO A; ODA N; YAMASAKI Y; MATSUURA N; MIYAKE H; YAMADA S; KIMURA R
    PHARMACOLOGICAL PROFILE OF TH-142177, NOVEL ORALLY-ACTIVE AT(1)-RECEPTOR ANTAGONIST
    Fundamental and clinical pharmacology
    
    Y. Nozawa et al., "PHARMACOLOGICAL PROFILE OF TH-142177, NOVEL ORALLY-ACTIVE AT(1)-RECEPTOR ANTAGONIST", Fundamental and clinical pharmacology, 11(5), 1997, pp. 395-401
38. HEAVEY ML; LAU WAK; PENNEFATHER JN
    TACHYKININ RECEPTORS MEDIATING NONCHOLINERGIC CONTRACTION OF THE GUINEA-PIG ISOLATED MAIN BRONCHUS IN RESPONSE TO FIELD STIMULATION
    Clinical and experimental pharmacology and physiology
    
    M.L. Heavey et al., "TACHYKININ RECEPTORS MEDIATING NONCHOLINERGIC CONTRACTION OF THE GUINEA-PIG ISOLATED MAIN BRONCHUS IN RESPONSE TO FIELD STIMULATION", Clinical and experimental pharmacology and physiology, 24(9-10), 1997, pp. 673-679
39. SCHMIDT PT; RASMUSSEN TN; HOLST JJ
    TACHYKININS MAY MEDIATE CAPSAICIN-INDUCED, BUT NOT VAGALLY INDUCED MOTILITY IN PORCINE ANTRUM
    Peptides
    
    P.T. Schmidt et al., "TACHYKININS MAY MEDIATE CAPSAICIN-INDUCED, BUT NOT VAGALLY INDUCED MOTILITY IN PORCINE ANTRUM", Peptides, 18(10), 1997, pp. 1511-1516
40. QUARTARA L; MAGGI CA
    THE TACHYKININ NK1 RECEPTOR - PART I - LIGANDS AND MECHANISMS OF CELLULAR ACTIVATION
    Neuropeptides
    
    L. Quartara e C.A. Maggi, "THE TACHYKININ NK1 RECEPTOR - PART I - LIGANDS AND MECHANISMS OF CELLULAR ACTIVATION", Neuropeptides, 31(6), 1997, pp. 537-563
41. BALMFORTH AJ; LEE AJ; WARBURTON P; DONNELLY D; BALL SG
    THE CONFORMATIONAL CHANGE RESPONSIBLE FOR AT(1) RECEPTOR ACTIVATION IS DEPENDENT UPON 2 JUXTAPOSED ASPARAGINE RESIDUES ON TRANSMEMBRANE-HELICES-III AND TRANSMEMBRANE-HELICES-VII
    The Journal of biological chemistry
    
    A.J. Balmforth et al., "THE CONFORMATIONAL CHANGE RESPONSIBLE FOR AT(1) RECEPTOR ACTIVATION IS DEPENDENT UPON 2 JUXTAPOSED ASPARAGINE RESIDUES ON TRANSMEMBRANE-HELICES-III AND TRANSMEMBRANE-HELICES-VII", The Journal of biological chemistry, 272(7), 1997, pp. 4245-4251
42. HEGDE VR; DAI P; CHU M; PATEL M; BRYANT R; TERRACCIANO J; DAS PR; PUAR MS
    NEUROKININ RECEPTOR INHIBITORS - FERMENTATION, ISOLATION, PHYSICOCHEMICAL PROPERTIES, STRUCTURE AND BIOLOGICAL-ACTIVITY
    Journal of antibiotics
    
    V.R. Hegde et al., "NEUROKININ RECEPTOR INHIBITORS - FERMENTATION, ISOLATION, PHYSICOCHEMICAL PROPERTIES, STRUCTURE AND BIOLOGICAL-ACTIVITY", Journal of antibiotics, 50(12), 1997, pp. 983-991
43. LUNDSTROM K; HAWCOCK AB; VARGAS A; WARD P; THOMAS P; NAYLOR A
    EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY
    European journal of pharmacology
    
    K. Lundstrom et al., "EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY", European journal of pharmacology, 337(1), 1997, pp. 73-81
44. ABDI A; JOHNS EJ
    THE EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS ON KIDNEY-FUNCTION IN 2-KIDNEY, 2-CLIP GOLDBLATT HYPERTENSIVE RATS
    European journal of pharmacology
    
    A. Abdi e E.J. Johns, "THE EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS ON KIDNEY-FUNCTION IN 2-KIDNEY, 2-CLIP GOLDBLATT HYPERTENSIVE RATS", European journal of pharmacology, 331(2-3), 1997, pp. 185-192
45. WILSON CJ; HUSAIN SS; STIMSON ER; DANGOTT LJ; MILLER KW; MAGGIO JE
    P-(4-HYDROXYBENZOYL)PHENYLALANINE - A PHOTOREACTIVE AMINO-ACID ANALOGAMENABLE TO RADIOIODINATION FOR ELUCIDATION OF PEPTIDE-PROTEIN INTERACTION APPLICATION TO SUBSTANCE-P RECEPTOR
    Biochemistry
    
    C.J. Wilson et al., "P-(4-HYDROXYBENZOYL)PHENYLALANINE - A PHOTOREACTIVE AMINO-ACID ANALOGAMENABLE TO RADIOIODINATION FOR ELUCIDATION OF PEPTIDE-PROTEIN INTERACTION APPLICATION TO SUBSTANCE-P RECEPTOR", Biochemistry, 36(15), 1997, pp. 4542-4551
46. INOUE H; NAGATA N; KOSHIHARA Y
    EFFECT OF THE TACHYKININ RECEPTOR ANTAGONISTS, SR-140333, PK-888, ANDSR-142801, ON CAPSAICIN-INDUCED MOUSE EAR EDEMA
    Inflammation research
    
    H. Inoue et al., "EFFECT OF THE TACHYKININ RECEPTOR ANTAGONISTS, SR-140333, PK-888, ANDSR-142801, ON CAPSAICIN-INDUCED MOUSE EAR EDEMA", Inflammation research, 45(6), 1996, pp. 303-307
47. ELLING CE; SCHWARTZ TW
    CONNECTIVITY AND ORIENTATION OF THE 7 HELICAL BUNDLE IN THE TACHYKININ NK-1 RECEPTOR PROBED BY ZINC SITE ENGINEERING
    EMBO journal
    
    C.E. Elling e T.W. Schwartz, "CONNECTIVITY AND ORIENTATION OF THE 7 HELICAL BUNDLE IN THE TACHYKININ NK-1 RECEPTOR PROBED BY ZINC SITE ENGINEERING", EMBO journal, 15(22), 1996, pp. 6213-6219
48. LEE WJ; KIM KS; YANG EK; LEE JH; LEE EJ; PARK JS; KIM HJ
    EFFECT OF BRAIN ANGIOTENSIN-II AT(1), AT(2), AND CHOLINERGIC RECEPTORANTAGONISM ON DRINKING IN WATER-DEPRIVED RATS
    Regulatory peptides
    
    W.J. Lee et al., "EFFECT OF BRAIN ANGIOTENSIN-II AT(1), AT(2), AND CHOLINERGIC RECEPTORANTAGONISM ON DRINKING IN WATER-DEPRIVED RATS", Regulatory peptides, 66(1-2), 1996, pp. 41-46
49. LIENARD F; THORNTON SN; MARTIAL FP; MOUSSEAU MC; NICOLAIDIS S
    ANGIOTENSIN-II RECEPTOR SUBTYPE ANTAGONISTS CAN BOTH STIMULATE AND INHIBIT SALT APPETITE IN RATS
    Regulatory peptides
    
    F. Lienard et al., "ANGIOTENSIN-II RECEPTOR SUBTYPE ANTAGONISTS CAN BOTH STIMULATE AND INHIBIT SALT APPETITE IN RATS", Regulatory peptides, 66(1-2), 1996, pp. 87-94
50. SUMANCHAUHAN N; MEECHAM KG; WEBDALE L; HUNTER JC; PRITCHARD MC; WOODRUFF GN; HILL DR
    THE INFLUENCE OF GUANYL NUCLEOTIDE ON AGONIST AND ANTAGONIST AFFINITYAT GUINEA-PIG CCK-B GASTRIN RECEPTORS - BINDING-STUDIES USING [H-3] PD140376/
    Regulatory peptides
    
    N. Sumanchauhan et al., "THE INFLUENCE OF GUANYL NUCLEOTIDE ON AGONIST AND ANTAGONIST AFFINITYAT GUINEA-PIG CCK-B GASTRIN RECEPTORS - BINDING-STUDIES USING [H-3] PD140376/", Regulatory peptides, 65(1), 1996, pp. 37-43
51. HORWELL D; PRITCHARD M; RAPHY J; RATCLIFFE G
    TARGETED MOLECULAR DIVERSITY - DESIGN AND DEVELOPMENT OF NONPEPTIDE ANTAGONISTS FOR CHOLECYSTOKININ AND TACHYKININ RECEPTORS
    Immunopharmacology
    
    D. Horwell et al., "TARGETED MOLECULAR DIVERSITY - DESIGN AND DEVELOPMENT OF NONPEPTIDE ANTAGONISTS FOR CHOLECYSTOKININ AND TACHYKININ RECEPTORS", Immunopharmacology, 33(1-3), 1996, pp. 68-72
52. LI ZY; BOSCH SM; SMITH TL; DIZ DI
    INTERACTIONS OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS AT IMIDAZOLINE GUANIDINIUM RECEPTOR-SITES IN RAT FOREBRAIN/
    Journal of cardiovascular pharmacology
    
    Z.Y. Li et al., "INTERACTIONS OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS AT IMIDAZOLINE GUANIDINIUM RECEPTOR-SITES IN RAT FOREBRAIN/", Journal of cardiovascular pharmacology, 28(3), 1996, pp. 425-431
53. MEYER G; BEINBORN M; SEWING KF
    CHARACTERIZATION OF CCKA RECEPTOR-MEDIATED PEPSINOGEN SECRETION IN PORCINE CHIEF CELLS
    Pharmacology
    
    G. Meyer et al., "CHARACTERIZATION OF CCKA RECEPTOR-MEDIATED PEPSINOGEN SECRETION IN PORCINE CHIEF CELLS", Pharmacology, 53(1), 1996, pp. 48-59
54. HJORTH SA; THIRSTRUP K; SCHWARTZ TW
    RADIOLIGAND-DEPENDENT DISCREPANCY IN AGONIST AFFINITIES ENHANCED BY MUTATIONS IN THE KAPPA-OPIOID RECEPTOR
    Molecular pharmacology
    
    S.A. Hjorth et al., "RADIOLIGAND-DEPENDENT DISCREPANCY IN AGONIST AFFINITIES ENHANCED BY MUTATIONS IN THE KAPPA-OPIOID RECEPTOR", Molecular pharmacology, 50(4), 1996, pp. 977-984
55. TIAN Y; WU LH; PU YM; HUANG CC; CHUNG FZ
    STRUCTURAL MOTIFS ENCODED BY INDIVIDUAL EXONS OF THE HUMAN NEUROKININ-1 RECEPTOR GENE INTERACT DIFFERENTIALLY WITH SELECTIVE AGONISTS AND ANTAGONISTS
    Journal of neurochemistry
    
    Y. Tian et al., "STRUCTURAL MOTIFS ENCODED BY INDIVIDUAL EXONS OF THE HUMAN NEUROKININ-1 RECEPTOR GENE INTERACT DIFFERENTIALLY WITH SELECTIVE AGONISTS AND ANTAGONISTS", Journal of neurochemistry, 67(3), 1996, pp. 1191-1199
56. GIRAULT S; SAGAN S; BOLBACH G; LAVIELLE S; CHASSAING G
    THE USE OF PHOTOLABELED PEPTIDES TO LOCALIZE THE SUBSTANCE-P-BINDING SITE IN THE HUMAN NEUROKININ-1 TACHYKININ RECEPTOR
    European journal of biochemistry
    
    S. Girault et al., "THE USE OF PHOTOLABELED PEPTIDES TO LOCALIZE THE SUBSTANCE-P-BINDING SITE IN THE HUMAN NEUROKININ-1 TACHYKININ RECEPTOR", European journal of biochemistry, 240(1), 1996, pp. 215-222
57. NIRULA V; ZHENG W; SOTHINATHAN R; SANDBERG K
    INTERACTION OF BIPHENYLIMIDAZOLE AND IMIDAZOLEACRYLIC ACID NONPEPTIDEANTAGONISTS WITH VALINE-108 IN TM-III OF THE AT(1) ANGIOTENSIN RECEPTOR
    British Journal of Pharmacology
    
    V. Nirula et al., "INTERACTION OF BIPHENYLIMIDAZOLE AND IMIDAZOLEACRYLIC ACID NONPEPTIDEANTAGONISTS WITH VALINE-108 IN TM-III OF THE AT(1) ANGIOTENSIN RECEPTOR", British Journal of Pharmacology, 119(8), 1996, pp. 1505-1507
58. MOSIMANN R; IMBODEN H; FELIX D
    THE NEURONAL ROLE OF ANGIOTENSIN-II IN THIRST, SODIUM APPETITE, COGNITION AND MEMORY
    Biological Reviews of the Cambridge Philosophical Society
    
    R. Mosimann et al., "THE NEURONAL ROLE OF ANGIOTENSIN-II IN THIRST, SODIUM APPETITE, COGNITION AND MEMORY", Biological Reviews of the Cambridge Philosophical Society, 71(4), 1996, pp. 545-559
59. RINDER J; LUNDBERG JM
    EFFECTS OF HCGRP-8-37 AND THE NK1-RECEPTOR ANTAGONIST SR-140.333 ON CAPSAICIN-EVOKED VASODILATION IN THE PIG NASAL-MUCOSA IN-VIVO
    Acta Physiologica Scandinavica
    
    J. Rinder e J.M. Lundberg, "EFFECTS OF HCGRP-8-37 AND THE NK1-RECEPTOR ANTAGONIST SR-140.333 ON CAPSAICIN-EVOKED VASODILATION IN THE PIG NASAL-MUCOSA IN-VIVO", Acta Physiologica Scandinavica, 156(2), 1996, pp. 115-122
60. LU XY; GROVE KL; ZHANG W; SPETH RC
    PHARMACOLOGICAL CHARACTERIZATION OF ANGIOTENSIN-II AT(2) RECEPTOR SUBTYPE HETEROGENEITY IN THE RAT ADRENAL-CORTEX AND MEDULLA
    Endocrine
    
    X.Y. Lu et al., "PHARMACOLOGICAL CHARACTERIZATION OF ANGIOTENSIN-II AT(2) RECEPTOR SUBTYPE HETEROGENEITY IN THE RAT ADRENAL-CORTEX AND MEDULLA", Endocrine, 3(4), 1995, pp. 255-261
61. GULLY D; JEANJEAN F; PONCELET M; STEINBERG R; SOUBRIE P; LEFUR G; MAFFRAND JP
    NEUROPHARMACOLOGICAL PROFILE OF NONPEPTIDE NEUROTENSIN ANTAGONISTS
    Fundamental and clinical pharmacology
    
    D. Gully et al., "NEUROPHARMACOLOGICAL PROFILE OF NONPEPTIDE NEUROTENSIN ANTAGONISTS", Fundamental and clinical pharmacology, 9(6), 1995, pp. 513-521
62. JOSEPH MP; MAIGRET B; BONNAFOUS JC; MARIE J; SCHERAGA HA
    A COMPUTER MODELING POSTULATED MECHANISM FOR ANGIOTENSIN-II RECEPTOR ACTIVATION
    Journal of protein chemistry
    
    M.P. Joseph et al., "A COMPUTER MODELING POSTULATED MECHANISM FOR ANGIOTENSIN-II RECEPTOR ACTIVATION", Journal of protein chemistry, 14(5), 1995, pp. 381-398
63. MAFFRAND JP; GULLY D; BOIGEGRAIN R; JEANJEAN F
    NEW POTENT AND SELECTIVE NONPEPTIDE ANTAGONISTS OF NEUROTENSIN RECEPTORS
    European journal of medicinal chemistry
    
    J.P. Maffrand et al., "NEW POTENT AND SELECTIVE NONPEPTIDE ANTAGONISTS OF NEUROTENSIN RECEPTORS", European journal of medicinal chemistry, 30, 1995, pp. 551-573
64. YOHANNAN MD; ERNSBERGER P
    HETEROGENEITY OF NEUROKININ, BINDING-SITES IN PORCINE RESPIRATORY-TRACT
    Peptides
    
    M.D. Yohannan e P. Ernsberger, "HETEROGENEITY OF NEUROKININ, BINDING-SITES IN PORCINE RESPIRATORY-TRACT", Peptides, 16(5), 1995, pp. 873-882
65. NAKA T; KUBO K; FURUKAWA Y
    NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS
    Yuki Gosei Kagaku Kyokaishi
    
    T. Naka et al., "NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS", Yuki Gosei Kagaku Kyokaishi, 53(9), 1995, pp. 802-810
66. CHUNG FZ; WU LH; TIAN Y; VARTANIAN MA; LEE H; BIKKER J; HUMBLET C; PRITCHARD MC; RAPHY J; SUMANCHAUHAN N; HORWELL DC; LALWANI ND; OXENDER DL
    2 CLASSES OF STRUCTURALLY DIFFERENT ANTAGONISTS DISPLAY SIMILAR SPECIES PREFERENCE FOR THE HUMAN TACHYKININ NEUROKININ(3) RECEPTOR
    Molecular pharmacology
    
    F.Z. Chung et al., "2 CLASSES OF STRUCTURALLY DIFFERENT ANTAGONISTS DISPLAY SIMILAR SPECIES PREFERENCE FOR THE HUMAN TACHYKININ NEUROKININ(3) RECEPTOR", Molecular pharmacology, 48(4), 1995, pp. 711-716
67. KIYAMA R; HONMA T; HAYASHI K; OGAWA M; HARA M; FUJIMOTO M; FUJISHITA T
    NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DESIGN, SYNTHESIS, AND IN-VITRO EVALUATION OF DIBENZO[A,D]CYCLOHEPTENE AND DIBENZO[B,F]OXEPIN DERIVATIVES - SEARCHING FOR BIOISOSTERES OF BIPHENYLYLTETRAZOLE USING A3-DIMENSIONAL SEARCH TECHNIQUE
    Journal of medicinal chemistry
    
    R. Kiyama et al., "NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DESIGN, SYNTHESIS, AND IN-VITRO EVALUATION OF DIBENZO[A,D]CYCLOHEPTENE AND DIBENZO[B,F]OXEPIN DERIVATIVES - SEARCHING FOR BIOISOSTERES OF BIPHENYLYLTETRAZOLE USING A3-DIMENSIONAL SEARCH TECHNIQUE", Journal of medicinal chemistry, 38(14), 1995, pp. 2728-2741
68. LIU JJ; PHILLIPS PA; BURRELL LM; BURTON BB; JOHNSTON CI
    HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NONPEPTIDE VASOPRESSIN ANTAGONISTS
    Clinical and experimental pharmacology and physiology
    
    J.J. Liu et al., "HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NONPEPTIDE VASOPRESSIN ANTAGONISTS", Clinical and experimental pharmacology and physiology, 21(2), 1994, pp. 121-124
69. SERVANT G; DUDLEY DT; ESCHER E; GUILLEMETTE G
    THE MARKED DISPARITY BETWEEN THE SIZES OF ANGIOTENSIN TYPE-2 RECEPTORS FROM DIFFERENT TISSUES IS RELATED TO DIFFERENT DEGREES OF N-GLYCOSYLATION
    Molecular pharmacology
    
    G. Servant et al., "THE MARKED DISPARITY BETWEEN THE SIZES OF ANGIOTENSIN TYPE-2 RECEPTORS FROM DIFFERENT TISSUES IS RELATED TO DIFFERENT DEGREES OF N-GLYCOSYLATION", Molecular pharmacology, 45(6), 1994, pp. 1112-1118
70. ITO H; SOGABE H; NAKARAI T; SATO Y; TOMOI M; KADOWAKI M; MATSUO M; TOKORO K; YOSHIDA K
    PHARMACOLOGICAL PROFILE OF FK480, A NOVEL CHOLECYSTOKININ TYPE-A RECEPTOR ANTAGONIST - COMPARISON TO LOXIGLUMIDE
    The Journal of pharmacology and experimental therapeutics
    
    H. Ito et al., "PHARMACOLOGICAL PROFILE OF FK480, A NOVEL CHOLECYSTOKININ TYPE-A RECEPTOR ANTAGONIST - COMPARISON TO LOXIGLUMIDE", The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 571-575
71. BURNS L; CLARK KL; BRADLEY J; ROBERTSON MJ; CLARK AJL
    MOLECULAR-CLONING OF THE CANINE ANGIOTENSIN-II RECEPTOR - AN AT1-LIKERECEPTOR WITH REDUCED AFFINITY FOR DUP753
    FEBS letters
    
    L. Burns et al., "MOLECULAR-CLONING OF THE CANINE ANGIOTENSIN-II RECEPTOR - AN AT1-LIKERECEPTOR WITH REDUCED AFFINITY FOR DUP753", FEBS letters, 343(2), 1994, pp. 146-150
72. GOSO C; POTIER E; MANZINI S; SZALLASI A
    COMPARISON OF TACHYKININ NK(1) RECEPTORS IN HUMAN IM9 AND U373-MG CELLS, USING ANTAGONIST (FK888, (PLUS-OR-MINUS)-CP-96,345, AND RP-67580) BINDING
    European journal of pharmacology
    
    C. Goso et al., "COMPARISON OF TACHYKININ NK(1) RECEPTORS IN HUMAN IM9 AND U373-MG CELLS, USING ANTAGONIST (FK888, (PLUS-OR-MINUS)-CP-96,345, AND RP-67580) BINDING", European journal of pharmacology, 254(3), 1994, pp. 221-227
73. DIETERICH KD; GRIGORIADIS DE; DESOUZA EB
    CORTICOTROPIN-RELEASING FACTOR RECEPTORS IN HUMAN SMALL-CELL LUNG-CARCINOMA CELLS - RADIOLIGAND BINDING, 2ND-MESSENGER, AND NORTHERN BLOT ANALYSIS DATA
    Endocrinology
    
    K.D. Dieterich et al., "CORTICOTROPIN-RELEASING FACTOR RECEPTORS IN HUMAN SMALL-CELL LUNG-CARCINOMA CELLS - RADIOLIGAND BINDING, 2ND-MESSENGER, AND NORTHERN BLOT ANALYSIS DATA", Endocrinology, 135(4), 1994, pp. 1551-1558
74. HOSOKI R; YANAGISAWA M; GUO JZ; YOSHIOKA K; MAEHARA T; OTSUKA M
    EFFECTS OF RP-67580, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON A PRIMARY AFFERENT-EVOKED RESPONSE OF VENTRAL ROOTS IN THE NEONATAL RAT SPINAL-CORD
    British Journal of Pharmacology
    
    R. Hosoki et al., "EFFECTS OF RP-67580, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON A PRIMARY AFFERENT-EVOKED RESPONSE OF VENTRAL ROOTS IN THE NEONATAL RAT SPINAL-CORD", British Journal of Pharmacology, 113(4), 1994, pp. 1141-1146
75. SCHAMBYE HT; VONWIJK B; HJORTH SA; WIENEN W; ENTZEROTH M; BERGSMA DJ; SCHWARTZ TW
    MUTATIONS IN TRANSMEMBRANE SEGMENT-VII OF THE AT(1) RECEPTOR DIFFERENTIATE BETWEEN CLOSELY-RELATED INSURMOUNTABLE AND COMPETITIVE ANGIOTENSIN ANTAGONISTS
    British Journal of Pharmacology
    
    H.T. Schambye et al., "MUTATIONS IN TRANSMEMBRANE SEGMENT-VII OF THE AT(1) RECEPTOR DIFFERENTIATE BETWEEN CLOSELY-RELATED INSURMOUNTABLE AND COMPETITIVE ANGIOTENSIN ANTAGONISTS", British Journal of Pharmacology, 113(2), 1994, pp. 331-333
76. MALCANGIO M; BOWERY NG
    EFFECT OF THE TACHYKININ NK1 RECEPTOR ANTAGONISTS, RP-67580 AND SR-140333, ON ELECTRICALLY-EVOKED SUBSTANCE-P RELEASE FROM RAT SPINAL-CORD
    British Journal of Pharmacology
    
    M. Malcangio e N.G. Bowery, "EFFECT OF THE TACHYKININ NK1 RECEPTOR ANTAGONISTS, RP-67580 AND SR-140333, ON ELECTRICALLY-EVOKED SUBSTANCE-P RELEASE FROM RAT SPINAL-CORD", British Journal of Pharmacology, 113(2), 1994, pp. 635-641
77. MAGGI CA; PATACCHINI R; MEINI S; QUARTARA L; SISTO A; POTIER E; GIULIANI S; GIACHETTI A
    COMPARISON OF TACHYKININ NK1 AND NK2 RECEPTORS IN THE CIRCULAR MUSCLEOF THE GUINEA-PIG ILEUM AND PROXIMAL COLON
    British Journal of Pharmacology
    
    C.A. Maggi et al., "COMPARISON OF TACHYKININ NK1 AND NK2 RECEPTORS IN THE CIRCULAR MUSCLEOF THE GUINEA-PIG ILEUM AND PROXIMAL COLON", British Journal of Pharmacology, 112(1), 1994, pp. 150-160
78. BALMFORTH AJ; BRYSON SE; AYLETT AJ; WARBURTON P; BALL SG; PUN KT; MIDDLEMISS D; DREW GM
    COMPARATIVE PHARMACOLOGY OF RECOMBINANT RAT AT(1A), AT(1B) AND HUMAN AT(1) RECEPTORS EXPRESSED BY TRANSFECTED COS-M6 CELLS
    British Journal of Pharmacology
    
    A.J. Balmforth et al., "COMPARATIVE PHARMACOLOGY OF RECOMBINANT RAT AT(1A), AT(1B) AND HUMAN AT(1) RECEPTORS EXPRESSED BY TRANSFECTED COS-M6 CELLS", British Journal of Pharmacology, 112(1), 1994, pp. 277-281
79. WANG ZY; TUNG SR; STRICHARTZ GR; HAKANSON R
    NONSPECIFIC ACTIONS OF THE NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS, CP-96,345, RP-67580 AND SR-48968, ON NEUROTRANSMISSION
    British Journal of Pharmacology
    
    Z.Y. Wang et al., "NONSPECIFIC ACTIONS OF THE NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS, CP-96,345, RP-67580 AND SR-48968, ON NEUROTRANSMISSION", British Journal of Pharmacology, 111(1), 1994, pp. 179-184
80. ISHIZAKI H; OHTAWA M
    INHIBITORY EFFECT OF THE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS ACTIVE METABOLITE, E-3174, ON CAMP-PHOSPHODIESTERASE - ADDITIONAL ACTION OF THE ANTAGONISTS
    Biochemical pharmacology
    
    H. Ishizaki e M. Ohtawa, "INHIBITORY EFFECT OF THE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS ACTIVE METABOLITE, E-3174, ON CAMP-PHOSPHODIESTERASE - ADDITIONAL ACTION OF THE ANTAGONISTS", Biochemical pharmacology, 48(1), 1994, pp. 201-204
81. WEYER U; SCHAFER R; HIMMLER A; MAYER SK; BURGER E; CZERNILOFSKY AP; STRATOWA C
    ESTABLISHMENT OF A CELLULAR-ASSAY SYSTEM FOR G-PROTEIN-LINKED RECEPTORS - COUPLING OF HUMAN NK2 AND 5-HT(2) RECEPTORS TO PHOSPHOLIPASE-C ACTIVATES A LUCIFERASE REPORTER GENE
    Receptors & channels
    
    U. Weyer et al., "ESTABLISHMENT OF A CELLULAR-ASSAY SYSTEM FOR G-PROTEIN-LINKED RECEPTORS - COUPLING OF HUMAN NK2 AND 5-HT(2) RECEPTORS TO PHOSPHOLIPASE-C ACTIVATES A LUCIFERASE REPORTER GENE", Receptors & channels, 1(3), 1993, pp. 193-200
82. RENZETTI AR; BARSACCHI P; CATALIOTO RM; CRISCUOLI M; MIZRAHI J
    DIFFERENTIAL EFFECT OF DITHIOTHREITOL AND DUP-753 ON ANGIOTENSIN-II RECEPTOR SUBTYPES IN BOVINE CEREBELLAR CORTEX
    Peptides
    
    A.R. Renzetti et al., "DIFFERENTIAL EFFECT OF DITHIOTHREITOL AND DUP-753 ON ANGIOTENSIN-II RECEPTOR SUBTYPES IN BOVINE CEREBELLAR CORTEX", Peptides, 14(5), 1993, pp. 1037-1041
83. EBERHARDT RT; KEVAK RM; KANG PM; FRISHMAN WH
    ANGIOTENSIN-II RECEPTOR BLOCKADE - AN INNOVATIVE APPROACH TO CARDIOVASCULAR PHARMACOTHERAPY
    Journal of clinical pharmacology
    
    R.T. Eberhardt et al., "ANGIOTENSIN-II RECEPTOR BLOCKADE - AN INNOVATIVE APPROACH TO CARDIOVASCULAR PHARMACOTHERAPY", Journal of clinical pharmacology, 33(11), 1993, pp. 1023-1038
84. TIMMERMANS PBMWM; WONG PC; CHIU AT; HERBLIN WF; BENFIELD P; CARINI DJ; LEE RJ; WEXLER RR; SAYE JAM; SMITH RD
    ANGIOTENSIN-II RECEPTORS AND ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    Pharmacological reviews
    
    P.B.M.W.M. Timmermans et al., "ANGIOTENSIN-II RECEPTORS AND ANGIOTENSIN-II RECEPTOR ANTAGONISTS", Pharmacological reviews, 45(2), 1993, pp. 205-251
85. SEABROOK GR; MAIN MJ; RAZZAQUE Z; LONGMORE J
    DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES
    European journal of pharmacology
    
    G.R. Seabrook et al., "DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES", European journal of pharmacology, 250(1), 1993, pp. 125-131
86. MOUSSAOUI SM; MONTIER F; CARRUETTE A; BLANCHARD JC; LADURON PM; GARRET C
    A NONPEPTIDE NK1-RECEPTOR ANTAGONIST, RP-67580, INHIBITS NEUROGENIC INFLAMMATION POSTSYNAPTICALLY
    British Journal of Pharmacology
    
    S.M. Moussaoui et al., "A NONPEPTIDE NK1-RECEPTOR ANTAGONIST, RP-67580, INHIBITS NEUROGENIC INFLAMMATION POSTSYNAPTICALLY", British Journal of Pharmacology, 109(1), 1993, pp. 259-264
87. CHATZIANTONIOU C; ARENDSHORST WJ
    ANGIOTENSIN RECEPTOR-SITES IN RENAL VASCULATURE OF RATS DEVELOPING GENETIC-HYPERTENSION
    The American journal of physiology
    
    C. Chatziantoniou e W.J. Arendshorst, "ANGIOTENSIN RECEPTOR-SITES IN RENAL VASCULATURE OF RATS DEVELOPING GENETIC-HYPERTENSION", The American journal of physiology, 265(6), 1993, pp. 60000853-60000862
88. KANG J; SUMNERS C; POSNER P
    ANGIOTENSIN-II TYPE-2 RECEPTOR-MODULATED CHANGES IN POTASSIUM CURRENTS IN CULTURED NEURONS
    The American journal of physiology
    
    J. Kang et al., "ANGIOTENSIN-II TYPE-2 RECEPTOR-MODULATED CHANGES IN POTASSIUM CURRENTS IN CULTURED NEURONS", The American journal of physiology, 265(3), 1993, pp. 30000607-30000616